Gender Differences in Parkinsonian Patients- a Swedish Register Study

Parkinson Disease Clinical Trial

Official title:

Gender Differences in Diagnostic Tools, Medication, Time to Medication and Non-motor Symptoms in Parkinsonian Patients- a Swedish Register Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04713306
• Other study ID #: XXXXX
• Status: Completed
• Start date: January 1, 2006
• Est. completion date: December 31, 2019

Study information

• Verified date: March 2021
• Source: Region Jönköping County
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

BACKGROUND: The complex impact of gender has been studied in different perspectives of health and disease in the literature. However, few attempts have been made to compile data from systematic disease specific registrations Swedish National Quality Registers play an important role in collecting large amounts of diagnose specific data, symptoms, and treatments. The subset Parkinson Registry has been in use for more than 20 years and are represented in all counties and hospitals where neurological care is provided in Sweden and offer optimal conditions to describe gender specific differences in the use of diagnostic tools, lead times and symptom profiles.

Description:

Aim: To study differences between gender in diagnostic tools, pharmacological interventions, and self-reported symptoms in Parkinson´s Disease (PD). METHODS: Data were extracted from the Swedish Neuro Registers, one of the Swedish National Quality Registers. A mix of urban and rural parts of the country were chosen and data were divided by gender. Self-reported first experienced PD related symptom was used to define the starting point when processing the data. Zero to three years from this point was defined as early symptoms and over three years as late symptoms. CONCLUSION: Differences between gender were seen in all chosen aspects, both diagnostically. Distinctions were also prominent in reported NonMotorSymptoms (NMS) profiles. These findings should be important to take into consideration for patients, professional staff, and caregivers in the daily work with gender mixed PD groups.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1217
• Est. completion date: December 31, 2019
• Est. primary completion date: May 1, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 1 Year to 100 Years

Eligibility

Inclusion Criteria:

• Participants registered in the Swedish Neuro Registers.
• Parkinson´s Disease
• Acceptance of extraction of data

Exclusion Criteria:

• non parkinsonian patients
• Participants in the Registries who have not given allowance of extraction of data.

Related Conditions & MeSH terms

• Parkinson Disease

Locations

Country	Name	City	State
Sweden	FUTURUM	Jönköping

Sponsors (3)

Lead Sponsor	Collaborator
Region Jönköping County	Jonkoping University, Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Differences between gender	investigations, medications,NonMotorSymptoms	2006-2020